| 0 |
VENTOUSE EXTRACTION |
2 |
0.0541 |
| 1 |
PREGNANCY WITH INJECTABLE CONTRACEPTIVE |
7 |
0.0329 |
| 2 |
PRODUCT CONTAMINATION CHEMICAL |
3 |
0.0138 |
| 3 |
CAUSTIC INJURY |
4 |
0.0128 |
| 4 |
CHEMICAL POISONING |
4 |
0.0107 |
| 5 |
SUBENDOCARDIAL ISCHAEMIA |
1 |
0.0090 |
| 6 |
CHEMICAL INJURY |
4 |
0.0049 |
| 7 |
LICE INFESTATION |
1 |
0.0048 |
| 8 |
EXPOSURE VIA INHALATION |
1 |
0.0046 |
| 9 |
SOMATIC DELUSION |
1 |
0.0041 |
| 10 |
INFESTATION |
1 |
0.0039 |
| 11 |
BURNS SECOND DEGREE |
5 |
0.0028 |
| 12 |
INSTILLATION SITE ERYTHEMA |
1 |
0.0019 |
| 13 |
APPLICATION SITE SCAB |
4 |
0.0019 |
| 14 |
AURICULAR SWELLING |
1 |
0.0017 |
| 15 |
CHOLINERGIC SYNDROME |
1 |
0.0016 |
| 16 |
ACTIVITIES OF DAILY LIVING DECREASED |
1 |
0.0016 |
| 17 |
APPLICATION SITE ULCER |
1 |
0.0014 |
| 18 |
EXPOSURE VIA DIRECT CONTACT |
1 |
0.0011 |
| 19 |
ELECTROCARDIOGRAM CHANGE |
1 |
0.0011 |
| 20 |
PARTNER STRESS |
1 |
0.0010 |
| 21 |
THERMAL BURN |
7 |
0.0010 |
| 22 |
HYPOPERFUSION |
1 |
0.0010 |
| 23 |
ACARODERMATITIS |
1 |
0.0009 |
| 24 |
APPLICATION SITE BURN |
4 |
0.0008 |
| 25 |
APPLICATION SITE PARAESTHESIA |
1 |
0.0008 |
| 26 |
TOBACCO USER |
1 |
0.0007 |
| 27 |
APPLICATION SITE VESICLES |
4 |
0.0006 |
| 28 |
DEMENTIA ALZHEIMER'S TYPE |
1 |
0.0006 |
| 29 |
BLOOD AMYLASE INCREASED |
1 |
0.0006 |
| 30 |
ALOPECIA AREATA |
1 |
0.0006 |
| 31 |
SKIN HYPOPIGMENTATION |
1 |
0.0006 |
| 32 |
PURULENCE |
1 |
0.0005 |
| 33 |
APPLICATION SITE EXFOLIATION |
2 |
0.0005 |
| 34 |
ACCIDENTAL EXPOSURE |
2 |
0.0005 |
| 35 |
DANDRUFF |
1 |
0.0005 |
| 36 |
CHEMICAL BURN OF SKIN |
1 |
0.0004 |
| 37 |
VENTRICULAR DYSFUNCTION |
1 |
0.0004 |
| 38 |
RHINALGIA |
1 |
0.0004 |
| 39 |
ACUTE PULMONARY OEDEMA |
2 |
0.0004 |
| 40 |
SCREAMING |
2 |
0.0003 |
| 41 |
EXPOSURE TO TOXIC AGENT |
1 |
0.0003 |
| 42 |
APPLICATION SITE REACTION |
2 |
0.0003 |
| 43 |
FRUSTRATION |
1 |
0.0003 |
| 44 |
THERAPEUTIC PRODUCT INEFFECTIVE |
1 |
0.0003 |
| 45 |
HYPERPHAGIA |
1 |
0.0003 |
| 46 |
MIOSIS |
2 |
0.0002 |
| 47 |
LIVE BIRTH |
2 |
0.0002 |
| 48 |
POISONING |
3 |
0.0002 |
| 49 |
ISCHAEMIA |
1 |
0.0002 |
| 50 |
NEPHROGENIC ANAEMIA |
1 |
0.0002 |
| 51 |
DRUG EXPOSURE DURING PREGNANCY |
7 |
0.0002 |
| 52 |
MULTIPLE DRUG OVERDOSE |
1 |
0.0002 |
| 53 |
FEMORAL NECK FRACTURE |
1 |
0.0002 |
| 54 |
STOMACH DISCOMFORT |
1 |
0.0002 |
| 55 |
PRODUCT ODOUR ABNORMAL |
2 |
0.0002 |
| 56 |
POOR QUALITY PRODUCT ADMINISTERED |
2 |
0.0002 |
| 57 |
PERONEAL NERVE PALSY |
1 |
0.0002 |
| 58 |
DERMATITIS CONTACT |
2 |
0.0002 |
| 59 |
RALES |
1 |
0.0002 |
| 60 |
PLEURISY |
1 |
0.0002 |
| 61 |
DERMATITIS ACNEIFORM |
1 |
0.0002 |
| 62 |
OLIGURIA |
1 |
0.0002 |
| 63 |
APPLICATION SITE IRRITATION |
2 |
0.0002 |
| 64 |
PRODUCT LABEL ISSUE |
1 |
0.0001 |
| 65 |
DRUG TOXICITY |
2 |
0.0001 |
| 66 |
RESPIRATION ABNORMAL |
1 |
0.0001 |
| 67 |
DROOLING |
1 |
0.0001 |
| 68 |
CARDIOGENIC SHOCK |
2 |
0.0001 |
| 69 |
RASH PUSTULAR |
1 |
0.0001 |
| 70 |
APPLICATION SITE PAIN |
3 |
0.0001 |
| 71 |
TROPONIN INCREASED |
1 |
0.0001 |
| 72 |
ACIDOSIS |
1 |
0.0001 |
| 73 |
APNOEA |
1 |
0.0001 |
| 74 |
ELECTROCARDIOGRAM ABNORMAL |
1 |
0.0001 |
| 75 |
NASAL DISCOMFORT |
1 |
0.0001 |
| 76 |
POLYURIA |
1 |
0.0001 |
| 77 |
HYPERAESTHESIA |
1 |
0.0001 |
| 78 |
UPPER-AIRWAY COUGH SYNDROME |
1 |
0.0001 |
| 79 |
VITAMIN D DECREASED |
1 |
0.0001 |
| 80 |
APPLICATION SITE ERYTHEMA |
3 |
0.0001 |
| 81 |
CARDIOTOXICITY |
1 |
0.0001 |
| 82 |
RENAL TUBULAR NECROSIS |
1 |
0.0001 |
| 83 |
UNINTENDED PREGNANCY |
1 |
0.0001 |
| 84 |
VENTRICULAR FIBRILLATION |
1 |
0.0001 |
| 85 |
SKIN DISORDER |
3 |
0.0001 |
| 86 |
SKIN INFECTION |
1 |
0.0001 |
| 87 |
ANGER |
3 |
0.0001 |
| 88 |
SCAB |
1 |
0.0001 |
| 89 |
MADAROSIS |
1 |
0.0001 |
| 90 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 91 |
NO THERAPEUTIC RESPONSE |
1 |
0.0001 |
| 92 |
CARDIOMEGALY |
1 |
0.0001 |
| 93 |
MUSCLE ATROPHY |
1 |
0.0001 |
| 94 |
ANOREXIA |
1 |
0.0001 |
| 95 |
PHARMACEUTICAL PRODUCT COMPLAINT |
2 |
0.0001 |
| 96 |
TACHYPNOEA |
1 |
0.0001 |
| 97 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 98 |
MASS |
1 |
0.0001 |
| 99 |
BLISTER |
4 |
0.0001 |
| 100 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 101 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 102 |
IMPAIRED QUALITY OF LIFE |
1 |
0.0001 |
| 103 |
CARDIOMYOPATHY |
1 |
0.0001 |
| 104 |
BLOOD POTASSIUM DECREASED |
2 |
0.0001 |
| 105 |
LACRIMATION INCREASED |
2 |
0.0001 |
| 106 |
CYANOSIS |
1 |
0.0001 |
| 107 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
3 |
0.0001 |
| 108 |
PSYCHOMOTOR HYPERACTIVITY |
1 |
0.0001 |
| 109 |
EXPIRED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 110 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 111 |
PERICARDITIS |
1 |
0.0001 |
| 112 |
SCAR |
1 |
0.0001 |
| 113 |
BURNING SENSATION |
4 |
0.0001 |
| 114 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 115 |
CRYING |
2 |
0.0001 |
| 116 |
END STAGE RENAL DISEASE |
1 |
0.0001 |
| 117 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 118 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 119 |
HALLUCINATION |
4 |
0.0001 |
| 120 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 121 |
CONVULSION |
3 |
0.0001 |
| 122 |
EAR PAIN |
1 |
0.0001 |
| 123 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 124 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
2 |
0.0001 |
| 125 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 126 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 127 |
DERMATITIS |
1 |
0.0000 |
| 128 |
ALOPECIA |
9 |
0.0000 |
| 129 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 130 |
OCULAR HYPERAEMIA |
2 |
0.0000 |
| 131 |
COMA |
2 |
0.0000 |
| 132 |
EPISTAXIS |
3 |
0.0000 |
| 133 |
AGGRESSION |
2 |
0.0000 |
| 134 |
CHRONIC KIDNEY DISEASE |
3 |
0.0000 |
| 135 |
RASH GENERALISED |
1 |
0.0000 |
| 136 |
ANHEDONIA |
1 |
0.0000 |
| 137 |
PAIN OF SKIN |
1 |
0.0000 |
| 138 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 139 |
PALLOR |
1 |
0.0000 |
| 140 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 141 |
FEELING COLD |
1 |
0.0000 |
| 142 |
LETHARGY |
2 |
0.0000 |
| 143 |
EYE IRRITATION |
2 |
0.0000 |
| 144 |
DYSSTASIA |
1 |
0.0000 |
| 145 |
MATERNAL EXPOSURE DURING PREGNANCY |
3 |
0.0000 |
| 146 |
DRUG ADMINISTRATION ERROR |
1 |
0.0000 |
| 147 |
BONE DENSITY DECREASED |
1 |
0.0000 |
| 148 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 149 |
LIP SWELLING |
1 |
0.0000 |
| 150 |
GAIT INABILITY |
1 |
0.0000 |
| 151 |
HYPERKALAEMIA |
1 |
0.0000 |
| 152 |
HYPOXIA |
1 |
0.0000 |
| 153 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 154 |
SKIN BURNING SENSATION |
2 |
0.0000 |
| 155 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
1 |
0.0000 |
| 156 |
EYE SWELLING |
1 |
0.0000 |
| 157 |
ASTHMA |
3 |
0.0000 |
| 158 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 159 |
EMOTIONAL DISTRESS |
3 |
0.0000 |
| 160 |
OSTEOPOROSIS |
1 |
0.0000 |
| 161 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 162 |
SKIN EXFOLIATION |
2 |
0.0000 |
| 163 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 164 |
SKIN IRRITATION |
1 |
0.0000 |
| 165 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 166 |
SWELLING |
2 |
0.0000 |
| 167 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 168 |
HEART RATE INCREASED |
2 |
0.0000 |
| 169 |
BRADYCARDIA |
1 |
0.0000 |
| 170 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 171 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 172 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 173 |
RASH PRURITIC |
1 |
0.0000 |
| 174 |
PAIN |
11 |
0.0000 |
| 175 |
ABDOMINAL PAIN |
4 |
0.0000 |
| 176 |
NASAL CONGESTION |
1 |
0.0000 |
| 177 |
VOMITING |
8 |
0.0000 |
| 178 |
SUICIDE ATTEMPT |
1 |
0.0000 |
| 179 |
STOMATITIS |
1 |
0.0000 |
| 180 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 181 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 182 |
LOSS OF CONSCIOUSNESS |
2 |
0.0000 |
| 183 |
HYPERHIDROSIS |
2 |
0.0000 |
| 184 |
AMNESIA |
1 |
0.0000 |
| 185 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 186 |
RENAL FAILURE |
2 |
0.0000 |
| 187 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 188 |
SLEEP DISORDER |
1 |
0.0000 |
| 189 |
OVERDOSE |
3 |
0.0000 |
| 190 |
INFECTION |
2 |
0.0000 |
| 191 |
AGITATION |
1 |
0.0000 |
| 192 |
DYSGEUSIA |
1 |
0.0000 |
| 193 |
HYPOAESTHESIA |
2 |
0.0000 |
| 194 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 195 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 196 |
DYSPNOEA |
7 |
0.0000 |
| 197 |
CARDIAC ARREST |
1 |
0.0000 |
| 198 |
TREMOR |
2 |
0.0000 |
| 199 |
TOXICITY TO VARIOUS AGENTS |
2 |
0.0000 |
| 200 |
MYOCARDIAL INFARCTION |
2 |
0.0000 |
| 201 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 202 |
TACHYCARDIA |
1 |
0.0000 |
| 203 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 204 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 205 |
MUSCLE SPASMS |
2 |
0.0000 |
| 206 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 207 |
CHEST PAIN |
2 |
0.0000 |
| 208 |
CARDIAC DISORDER |
1 |
0.0000 |
| 209 |
ANXIETY |
3 |
0.0000 |
| 210 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 211 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 212 |
ERYTHEMA |
2 |
0.0000 |
| 213 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 214 |
DRUG INEFFECTIVE |
12 |
0.0000 |
| 215 |
INFLUENZA |
1 |
0.0000 |
| 216 |
INCORRECT DOSE ADMINISTERED |
2 |
0.0000 |
| 217 |
SEIZURE |
1 |
0.0000 |
| 218 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 219 |
DIARRHOEA |
5 |
0.0000 |
| 220 |
DRY SKIN |
1 |
0.0000 |
| 221 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 222 |
ACUTE KIDNEY INJURY |
1 |
0.0000 |
| 223 |
DRUG INTERACTION |
1 |
0.0000 |
| 224 |
DRUG DEPENDENCE |
1 |
0.0000 |
| 225 |
COVID-19 |
1 |
0.0000 |
| 226 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 227 |
PRURITUS |
2 |
0.0000 |
| 228 |
NAUSEA |
4 |
0.0000 |
| 229 |
HYPOTENSION |
1 |
0.0000 |
| 230 |
SOMNOLENCE |
1 |
0.0000 |
| 231 |
ARTHRALGIA |
2 |
0.0000 |
| 232 |
RASH |
2 |
0.0000 |
| 233 |
MALAISE |
2 |
0.0000 |
| 234 |
WEIGHT INCREASED |
1 |
0.0000 |
| 235 |
DEPRESSION |
1 |
0.0000 |
| 236 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 237 |
FATIGUE |
3 |
0.0000 |
| 238 |
COUGH |
1 |
0.0000 |
| 239 |
OFF LABEL USE |
3 |
0.0000 |
| 240 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 241 |
PNEUMONIA |
1 |
0.0000 |
| 242 |
FALL |
1 |
0.0000 |
| 243 |
PYREXIA |
1 |
0.0000 |
| 244 |
DIZZINESS |
1 |
0.0000 |
| 245 |
HEADACHE |
1 |
0.0000 |